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Hemagglutinin-esterases (HE) are viral envelope proteins present in some members from the toro-, corona- and
orthomyxovirus families, all related with enteric and/or respiratory tract infections. HE proteins mediate reversible
binding to sialic acid receptor determinants, very abundant glycan residues in the enteric and respiratory tracts. The
role of the HE protein during the torovirus infection cycle remains unknown, although it is believed to be important
in the natural infection process. The phylogenetic analysis of HE coding sequences from porcine torovirus (PToV)
field strains revealed the existence of two distinct HE lineages. In a previous study, PToV virus strains with HE
proteins from the two lineages were found coexisting in a pig herd, and they were even obtained from the same
animal at two consecutive sampling time points. In this work, we report antigenic differences between the two HE
lineages, and discuss the possible implications that the coexistence of viruses belonging to both lineages might
have on the spread and sustainment of PToV infection in the farms.Introduction
Toroviruses (ToV) are enveloped, positive single-stranded
RNA viruses of cattle, horses, pigs and humans [1]. They
have been associated with enteric infections and diarrhea,
especially in young animals and children [2], and are con-
sidered a potential zoonotic threat [3]. The Torovirinae
subfamily of the Coronaviridae family (order Nidovirales)
comprises four species: equine torovirus (EToV), bovine
torovirus (BToV), porcine torovirus (PToV) and human
torovirus (HToV). The few epidemiological studies per-
formed in different countries indicate high prevalences of
these viruses [4-6]. The torovirus’s genome size (~ 28 kb)
and organization are very similar to those of other corona-
viruses, with two huge overlapping open reading frames
(ORF) shaping the 5′-end of the genome, where the
replicase/transcriptase machinery is encoded, and a final
third of the RNA molecule hosting the coding sequences
for the four structural proteins (from 5′ to 3′): spike (S),
hemagglutinin-esterase (HE), membrane (M), and nucleo-
capsid (N) [7]. By analogy to other nidoviruses, the S* Correspondence: drodrig@cnb.csic.es
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reproduction in any medium, provided the orprotein is considered to be the putative receptor binding
molecule. Copies of this molecule form the large spikes
protruding from the viral particles as shown by electron
microscopy [8,9]. The HE protein forms homodimers
which make up the smaller spikes [5,10]. This HE protein
is a class I membrane glycoprotein of about 65 kDa that
belongs to the receptor destroying enzyme (RDE) protein
family. As an RDE protein HE provides reversible binding
to glycosylated surfaces [11] due to its ability to bind sialic
acids and catalyze the disruption of that binding by means
of its acetyl-esterase activity. The 3D structure and sialic
acid preference of PToV- (strain Markelo) and BToV-
(strain Breda) HE proteins have been solved [12]. Two
main domains have been defined in the HE monomer of
both proteins: the enzymatic acetyl-esterase region (E)
and the receptor binding (R) or lectin domain.
Despite the great amount of knowledge acquired on
this protein family, it is not yet clear what is the exact
role of HE during the torovirus infectious cycle. The
EToV, the only cell culture adapted torovirus, as well as
different BToV strains that could be isolated in cell cul-
ture, all lack a functional HE protein [13-16] due to de-
letions or mutations in the HE gene, acquired during
their adaptation to in vitro growth conditions. Thus, HEal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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these viruses, as it occurs with the coronavirus murine
hepatitis virus (MHV) [17]. However, the maintenance of
the HE protein in a vast majority of new PToV and BToV
field isolated strains indicates that it has to play an impor-
tant function during in vivo infections. Several hypothe-
tical functions have been postulated for the ToV-HE:
(i) being a viral co-receptor, (ii) digestion of mucus layers
to allow the virus to reach the target cells in the respira-
tory and/or enteric tracts, (iii) release of viral particles
bound to decoy receptors, (iv) influencing host/cell tro-
pism, or as recently proposed by de Groot’s group, (v) ac-
ting as a molecular timer in the virus pre-attachment step
to the host-cell [18].
Two PToV-HE lineages have been identified, with rep-
resentative strains being Markelo and P4 [19]. They share
an amino acid sequence homology of 80%. Recently, du-
ring a longitudinal survey of PToV in a Spanish pig herd,
several PToV-HE isolates representative of both lineages
were identified [20], and similar findings were described
from a survey performed in Korea [21]. In the first case,
the two PToV-HE lineages were detected even within the
same animal at two sequential sampling time points, indi-
cating that both PToV strains carrying different HE pro-
teins coexisted on the same farm infecting the same
piglets, and suggesting that the immune response gene-
rated against one PToV strain did not protect the animals
against the infection by the other strain. To further inves-
tigate this hypothesis PToV-HE proteins corresponding to
each HE lineage were expressed, characterized, and used
to track the anti-HE response in the animals from the
farm where the PToV strains were obtained. The analysis
of serum samples by hemagglutination inhibition assay
and ELISA revealed antigenic differences between the two
HE lineages.
Materials and methods
Cells, viruses and antisera
BSC40 (African green monkey kidney cells) cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM),
supplemented with 5% heat-inactivated neonatal calf
serum (NCS), non-essential amino acids (1%), genta-
micin (50 μg/mL), penicillin (100 IU/mL), streptomycin
(100 μg/mL) and fungizone (0.5 μg/mL).
Vaccinia virus (VACV), strain Western Reserve (WR)
[22], and the recombinant VACV (rVV) derivatives were
propagated and titrated in BSC40 cells.
To obtain a polyclonal antiserum against PToV-HE
(αHE), a New Zealand rabbit was inoculated with two dif-
ferent peptides coupled to Keyhole limpet hemocyanin
(KLH). Peptides comprising residues 51–67 (CTNPSTPN
SLDIPQQLC) and 152–162 (LTPPENIPSHC) of PToV-
HE-Bres [GenBank: FJ232070] [23] were chemically syn-
thesized at the Proteomics facility of our institution afterselection of target PToV-HE antigenic regions by bioin-
formatic analysis with Protean software (DNASTAR Inc.
Madison, WI, USA).
Pig serum samples
The serum sample collection and their treatment were
previously described [20]. The samples corresponded to
12 animals from three different litters (A, B and C; four
animals per litter) of the same farm, and were collected
at 1-, 3-, 7-, 11-, and 15-weeks of age. Serum samples
from the corresponding sow of each litter (n = 3) col-
lected at the first day of sampling were also obtained.
Sequence analysis and modeling
Sequences were retrieved from the NCBI database. The
sequence analysis was performed by comparing an equal
number of sequences related to each PToV lineage,
obtained from viruses identified in three different geo-
graphical regions: Italy, Spain and Korea. Sequences re-
presenting the Markelo lineage were from the PToV
strains Markelo [GenBank: GU299776.1], P78 [GenBank:
AJ575367.1], 52.7 [GenBank: GU299776.1], 14.7 [GenBank:
GU299775.1], 07-56-14 [GenBank: FJ555594.1] and 07-56-
23 [GenBank: FJ555596.1]. The HE sequences represen-
ting the P4 lineage were from PToV strains P4 [GenBank:
AJ575364.1], BRES [GenBank: FJ232070.1], 52.11 [Gen-
Bank: GU299777.1], 12.11 [GenBank: GU299773.1], 07-
56-11 [GenBank: FJ555593.1] and 07-56-22 [GenBank:
FJ555595.1]. Protein sequences were aligned using a
ClustalW algorithm (MegAling, Lasergene, DNAstar, Inc).
Alignment modeling was performed on the Markelo HE
structural model [PDB: 3I1K] using Pymol v1.1 (DeLano
Scientific LLC). The amino acid residues that are con-
served in all sequences from one lineage but are different
from those in the strains corresponding to the other
lineage are depicted in blue. Other residues that are con-
served in all sequences or are non-lineage specific are
depicted in red.
Generation of rVV expressing PToV-HE genes
pGemT plasmids with PToV-HE coding sequences from
isolates 52.7 and 52.11 [20] were used to sub-clone the in-
dicated PToV-HE sequences into the pJR101 VACV trans-
fer vector [24] by asymmetric digestion with restriction
endonucleases BamHI and NcoI. The resulting plasmids,
pJR-HE52.7 and pJR-HE52.11, carried the HE genes under
the control of the VACV synthetic early/late promoter
(pe/L). Insertion of the HE genes into the VACV hemag-
glutinin locus (HA) was achieved by homologous re-
combination between the transfer vectors and the virus
genome following standard procedures [25]. The resulting
rVV-HE52.7 and rVV-HE52.11 viruses were selected and
grown following standard procedures to yield viral stocks
that were titrated and stored at −80 °C until use. A control
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nerated in parallel under the same procedures using the
empty pJR101 vector.
rVV expressing soluble forms of HE52.7 and HE52.11
proteins fused to the c-myc tag were also generated to
facilitate protein purification by affinity chromatography.
For this purpose, the sequences coding for the fusion
proteins were cloned into the pJR101 vector, and the
corresponding rVV were obtained as described above.
Western blot analysis
BSC40 cells infected with the corresponding rVV at a
multiplicity of infection (MOI) of 5 plaque-forming units
per cell (PFU/cell) were collected at 24 hours post-
infection (hpi) in Laemmli sample buffer. Expression of
PToV-HE proteins in infected cells was analyzed by poly-
acrylamide gel electrophoresis (SDS-PAGE) and Western
blot with the rabbit polyclonal αHE serum. After incuba-
tion with a horseradish peroxidase-conjugated secondary
antibody (Sigma-Aldrich, Saint-Louis, MO, USA), the re-
active bands were detected by chemoluminescence using
the commercial ECL reagent (GE Healthcare, Uppsala,
Sweden).
Immunofluorescence microscopy
Subconfluent BSC40 cell monolayers were grown in
12 mm-diameter coverslips and infected with rVV-
HE52.7, rVV-HE52.11, or the control virus rVV-HA- at an
MOI of 5 PFU/cell. At 7 hpi, cells were washed, fixed with
4% paraformaldehyde and permeabilized with 0.5% Triton
X-100 in PBS. After a blocking step with 20% fetal calf
serum (FCS) in PBS, cells were incubated for 1 h with
αHE polyclonal antiserum diluted (1:1000) in PBS contai-
ning 20% FCS, washed three times and stained with Alexa
Fluor 594 goat anti-rabbit IgG (Molecular Probes™, Life
Technologies, Carlsbad, CA, USA) at 1:500 dilution.
DAPI reagent (4′, 6′-diamidino-2-phenylindole) (Molecular
Probes™) was used to stain cell nuclei. After washing with
PBS, coverslips were mounted on microscope slides using
the ProLong® Gold anti-fade reagent from Molecular
Probes™. Images were captured with a confocal Radiance
2100 system (Bio-Rad, München, Germany) and pro-
cessed using ImageJ [26] and Adobe Photoshop CS4
(Adobe System Inc., San José, CA, USA).
Cell extracts for HE functional assays
Confluent BSC40 cell monolayers seeded in 150 mm
plates were infected with rVV-HE52.7 and rVV-HE52.11
at a MOI of 5. At 24 hpi cells were rinsed with PBS and
harvested. After a centrifugation step at 3000 × rpm for
10 min, cell pellets were resuspended in TNE buffer
(1 mM Tris-Cl, 75 mM EDTA and 25 mM NaCl) and
subjected to three successive freeze-thaw cycles and son-
ication. The soluble fractions were stored at −80 °C untilneeded. To obtain esterase inactivated PToV-HE cell
extracts, rVV infected BSC40 monolayers were treated
with 5 mM diisopropyl fluorophosphate (DFP; Sigma-
Aldrich) for 30 min at room temperature before scraping
the cells. Any remaining excess of DFP was removed
after thoroughly washing the cells with ice-cold PBS.
Protein concentrations in the cell extracts were deter-
mined by Bradford reaction (Bio-Rad Protein Assay)
using known amounts of purified bovine serum albumin
(BSA) as standards.
Esterase assays
Specific acetyl-esterase activity of both recombinant HE
proteins (HE52.7 and HE52.11) was tested by an in situ
staining assay as previously described [27]. BSC40 cell
monolayers were infected with the corresponding rVV-HE
and with rVV-HA- as the negative control. At 48 hpi viral
plaques expressing HE were visualized after incubation
with α-naphtyl acetate-Fast Blue BB solution (ANAE assay
kit, Sigma-Aldrich) according to the manufacturer’s in-
structions. Cell monolayers were then stained with crystal
violet solution (0.5% in 20% methanol) to visualize all viral
plaques.
Sialate-O-acetylesterase activity of rVV-infected BSC40
cell extracts in TNE solution was determined with the
synthetic substrate p-nitrophenyl acetate (pNPA; Sigma-
Aldrich) as previously described [28]. Briefly, cell extracts
were incubated with 3 mM pNPA at 37 °C, and the hy-
drolysis of pNPA was recorded by reading the absorbance
at 405 nm at different times. The enzymatic activity per
μg of cell lysate, after subtracting the background activity
present in the control cell extract infected with rVV-HA-,
was calculated as previously described [17].
Hemagglutination and hemagglutination inhibition assays
These assays were performed in U-shaped 96-well plates
(Nunc, Roskilde, Denmark). Mouse (Mus musculus, strain
Swiss) blood obtained from the retro-orbital cavity of
anesthetized animals was collected in two volumes of ste-
rile Alsever solution to prevent clotting. Animals were
handled following the guidelines of the Animal Experi-
mentation Committee of our institution, in strict accor-
dance with the Spanish law (RD 1201–2005). The red
blood cells (RBC) obtained were washed with Alsever so-
lution, counted and diluted in PBS to obtain a 10% stock
solution (10% solution corresponds to 8 · 108 RBCs per
mL). Hemmagglutination assays (HA) were set-up using
two-fold dilutions of extracts from DFP-treated and un-
treated rVV-infected cells. Fresh mouse RBC in PBS solu-
tion were added (50 μL) to the HE containing wells and
incubated for two hours at 4 °C. Hemagglutination was
scored and documented by photography, and plates were
then placed at 37 °C and a second image was taken after
1 h incubation at this temperature. The hemagglutination
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lished as the reciprocal of the highest dilution causing
hemagglutination.
For the hemagglutination inhibition assays (HI), HE
cell extracts (4 HAU in 25 μL PBS) were incubated (1 h
at 3 °C) with two-fold serial dilutions of kaolin treated
pig sera [29] prior to adding 50 μL per well of a mouse
erythrocyte suspension (final concentration of 0.5%). The
HI titer was defined as the reciprocal of the highest serum
dilution that completely inhibited hemagglutination by the
viral antigen. Serum samples with HI titers higher than 3
log2 were considered positive.
Purification of c-myc-tagged HE proteins
Extracts from BSC40 cells infected with rVV-HE52.7-myc
or rVV-HE52.11-myc, were prepared as described above
in TNE buffer containing 1% NP40. The soluble fractions
were transferred to new tubes containing anti-c-myc
coated beads previously equilibrated in TNE buffer (MBL,
Naka-ku Nagoya, Japan). After 1 h incubation at 4 °C the
mixtures of bead suspension and cell lysates were centri-
fuged in spin columns, washed thrice, and proteins were
eluted with a c-myc tag peptide. The reagents and the
protocol for the protein purification procedure were pro-
vided by the supplier. The purified proteins were analyzed
by SDS-PAGE and Western blot with the αHE polyclonal
serum and anti-c-myc monoclonal antibodies to confirm
their identity (Clontech, Takara Bio Inc., Otsu, Shiga,
Japan), and by Coomasie blue staining of the gel to de-
termine their purity and concentration using different
amounts of BSA as the reference.
Enzyme-linked immunosorbent assay (ELISA)
An indirect ELISA was set up to detect antibodies
against PToV-HE proteins in pig serum samples. The
optimal protein concentration was established by
checkerboard titration with positive and negative pig
control sera. Paired rows of a 96-well microtiter plate
(Maxisorp, Nunc) were coated overnight (4 °C) with
purified HE52.7-myc and HE52.11-myc proteins diluted
at a 1.25 μg/mL concentration. Plates were thoroughly
washed after each step by rinsing the plates thrice with
PBS containing 0.05% Tween 20 (PBST). After coating,
plates were blocked for 2 h at 37 °C with PBST-3% BSA.
Then, 50 μL of each serum sample diluted 1:100 in
PBST-1% BSA was added in paired wells and incubated
1 h at 37 °C. A commercial goat anti-pig IgG secondary
antibody conjugated to horseradish peroxidase (Sigma-
Aldrich) was used. The enzymatic reaction was developed
using o-phenylenediamine dihydrochloride (OPD-FAST™,
Sigma-Aldrich), and stopped after 10 min by adding
50 μL/well of 2 N sulphuric acid. Optical densities at
492 nm (O.D.492) were recorded with a multichannel spec-
trophotometer (Titertek Multiscan MCC/340). Asnegative control serum, a pool of sera from caesarian-
derived, colostrum-deprived (CD/CD) pigs kept under
germ free conditions (spf) was used, and the positive
control serum was a commercial porcine serum (AbD
Serotec, Kidlington, UK) previously determined to con-
tain antibodies against PToV [23]. The ELISA cut-off
was established for each antigen as the mean of the
O.D. of negative control serum plus three times the
standard deviation (HE52.7-myc cut off = 0.08; and
HE52.11-myc cut off = 0.10).
A previously described indirect ELISA was used to
detect antibodies to the highly conserved PToV nucleo-
capsid protein [23].
Statistical analysis
Statistical analyses of HI and ELISA sera reactivities ob-
tained from animals grouped by ages against both PToV-
HE52.7 and PToV-HE52.11 were performed using two
tailed t Student’s. Means ± standard error of the mean
(SEM) for each group are shown.
Results
Expression of PToV-HE proteins
The detection of PToV strains belonging to the two de-
fined HE lineages, represented by Markelo and P4 strains,
in piglet fecal swabs collected on a Spanish farm in the
course of a PToV longitudinal survey was previously
described [20]. Interestingly, two PToV strains, one from
each of the described lineages were isolated from the same
animal (pig 52, litter B) at different time-points of the pig-
let’s life, at 7- and 11-weeks of age. The HE from the virus
isolated at week 7, named PToV-HE52.7, was 94.4% hom-
ologous to Markelo HE at the amino acid level, whereas
the protein from the virus found at week 11, HE52.11, was
more closely related to P4 HE (93.4% homology). The dir-
ect comparison between both PToV-HE52.7 and PToV-
HE52.11 gave a 77.9% identity, a homology that is similar
to those obtained when comparing previous reported HE
sequences from both HE lineages [19,21]. To study the
amino acid differences between both HE lineages, a
sequence alignment from HE proteins corresponding to
viruses identified in three different geographical regions
was performed. The HE sequences from the Spanish
PToV strains HE12.11, HE52.11, HE14.7 and HE52.7 [20]
were compared with those from other European strains
Markelo, P78, P4 [19] and Bres [23], and from Korean
strains 56–14 and 56–23 and 56–11 and 56–22 [21]. The
alignment shows that several amino acid positions were
conserved in a lineage specific manner (Figure 1A, grey
shade), even in the geographically distant Korean strains.
These lineage specific amino acids were located in the
Markelo tridimensional structural model [12], and, as
shown in Figure 1B, these differential amino acids (blue
balls) were found mainly placed on the surface of the
Figure 1 Sequence analysis of HE proteins from PToV strains representative of both lineages. (A) Multiple alignments of HE sequences.
(B) Modeling over the Markelo HE structure (in red) of amino acid residues differing between Markelo and P4 lineages (in blue).
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potential antigenic differences between both HE lineages.
To study the HE proteins from PToV-HE isolates 52.7
and 52.11 as the model for the Markelo and P4 HE line-
ages, and search for potential antigenic differences between
them, both proteins were expressed by the recombinant
VACV methodology. rVV carrying the corresponding
HE52.7 or HE52.11 coding sequences inserted into the HA
locus of the VACV genome, were generated (rVV-HE52.7
and rVV-HE52.11). In addition, a VACV lacking a func-
tional HA protein, rVV-HA-, was produced to serve as the
negative control. PToV-HE proteins expressed upon infec-
tion of BSC40 cells with the rVV were specifically detected
by Western blot and immunofluorescence microscopy
using the αHE rabbit antiserum. Western blot analysis
under denaturing conditions detected both HE52.7 and
HE52.11 proteins in rVV-infected cell monolayers with
the expected 65 kDa molecular weight (Figure 2A) corre-
sponding to the glycosylated form of the protein [10].
Both HE proteins were expressed at a similar extent. Re-
garding the subcellular localization of recombinant HE
proteins analyzed by immunofluorescence, the PToV-HE
specific signal was widely distributed in the cytoplasm as
well as associated to the nuclear and plasma membranes
of BSC40 cells infected with either rVV-HE52.7 or rVV-
HE52.11 but not in rVV-HA-- infected cells (Figure 2B).
PToV-HE functional characterization
The acetyl-esterase activity of the recombinant PToV-
HE52.7 and HE52.11 proteins was analyzed by in situ
staining of infected cells by the ANAE assay [27]. Infected
cells surrounding viral plaques produced by both rVV-
HE52.7 and rVV-HE52.11 show a brownish staining
whereas the rVV-HA- derived plaques remained unstained
(Figure 3A). PToV-HE52.7 and rVV-HE52.11 were also
able to hydrolyze the acetyl group from the synthetic sub-
strate p-nitrophenol acetate in the pNPA assay [28] per-
formed with extracts from infected cells. The graph in
Figure 3B shows the specific pNPA hydrolysis obtained
with the HE proteins. Both HE52.7 and HE52.11 cellFigure 2 Expression of PToV-HE52.7 and PToV-HE52.11 proteins. (A) W
infected (MOI 5) with rVV-HE52.7, rVV-HE52.11 or rVV-HA-. Infected cells we
membrane and reacted with the αHE antibody. α-Tubulin signalling was ta
kDa. (B) Immunofluorescence microscopy of BSC40 cells infected with rVV
αHE antibody followed by a secondary antibody coupled to Alexa Fluor 59extracts show similar activities (2.9 and 3.6 mU/μg lysate
respectively). PToV-HE acetyl-esterase activity of the
infected cell extracts was completely and irreversibly
inhibited when the rVV-infected BSC40 cell monolayers
were treated with the serine-esterase inhibitor DFP (see
Materials and methods) as shown in Figure 3B. No ester-
ase activity could be detected in extracts from cells
infected with rVV-HA-, either untreated or treated with
DFP.
The lectin activity of HE52.7 and HE52.11 proteins was
tested by hemagglutination assay using mouse erythro-
cytes. The hemagglutination assay was set up with two
fold serial dilutions of DFP treated (DFP+) and DFP un-
treated (DFP-) cell extracts, starting from 2 μg per well of
total protein. The lysate from cells infected with rVV-HA-
served as the negative control. At 4 °C, both DFP+
and DFP- rVV-HE cell extracts were able to induce
hemagglutination of mouse RBC at a similar HA titer,
whereas the HA- cell extract did not hemagglutinate the
mouse RBC at any of the amounts tested (Figure 3C).
When plates were placed at 37 °C, the hemagglutination
net induced by DFP- cell extracts was disrupted due to
their acetyl-esterase activity at that temperature, however
hemagglutination was maintained in DFP-treated HE con-
taining wells, indicating that the acetyl-esterase activity
was completely inhibited (Figure 3D).
The esterase activity and receptor binding results show
that both recombinant PToV-HE proteins were biolo-
gically active, indicating the acquisition of proper con-
formational folding.
Inhibition of PToV-HE-induced hemagglutination by pig
serum samples
The hemagglutination caused by HE proteins is due to
the binding of their lectin or receptor binding domain
to specific sialic acid determinants present on the sur-
face of RBC. Hence, in order to examine the potential
existence of antigenic differences between the two line-
ages of PToV-HE proteins, piglet serum samples were
analyzed with an HI assay to detect the presence ofestern blot detection of HE proteins in extracts from BSC40 cells
re fractionated by 10% SDS-PAGE, transferred to a nitrocellulose
ken along as a loading standard. Molecular size markers are given in
(MOI 5). Cells were fixed at 7 hpi, permeabilized and incubated with
4 (red). Cell nuclei were stained using DAPI (blue). Scale bar: 10 μm.
Figure 3 Functional characterization of recombinant PToV-HE52.7 and PToV-HE52.11 proteins. (A) ANAE in situ staining of rVV plaques
produced in BSC40 infected with rVV-HE52.7, rVV-HE52.11 or rVV-HA- (~ 100 PFU per well). After the ANAE assay cell monolayers were stained
with crystal violet to visualize all viral plaques. (B) Acetylesterase activity in extracts from BSC40 cells infected with rVV expressing PToV-HEs. Cells
infected (MOI 5) with rVV-HE52.7 and rVV-HE52.11 or with the control virus rVV-HA- were harvested at 24 hpi, resuspended in TNE buffer and
tested for acetyl esterase activity by incubation with 1 mM pNPA reagent. Background corrected hydrolysis of pNPA (in nmol), measured at
405 nm along a time span (min) is shown in the graph. (C-D) Hemagglutination assays with mouse RBC (0.5%) and 2-fold dilutions of both
DFP-treated (+DFP) and untreated (−DFP) rVV-infected cell extracts resuspended in TNE buffer, recorded after incubation at 4 °C (C) and at 37 °C,
(D). The negative controls (C-) correspond to wells where RBC were incubated with TNE buffer.
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that prevents the RBC hemagglutination. In the HI test,
DFP inactivated HE52.7 and HE52.11 cell lysates were
used to avoid artifacts in the assay derived from the HE
esterase activity. Using serum samples from the longitu-
dinal survey, different HI antibody response dynamics
against HE52.7 and HE52.11 proteins were observed.
Anti-HE52.7 antibodies were detected at week 1 in 65% of
the piglets (7/12) (Figure 4G), even though all piglets from
litter B were negative against that particular lineage at that
time-point (Figure 4C). With respect to the anti-HE52.11
inhibitory reaction in week 1 sera, none of the animals in
litter C was reactive against it (Figure 4F), and only one
piglet from litter B had specific anti-HE52.11 HI reactivity
(Figure 4D). However all piglets from litter A had high HI
titers towards this lineage, in agreement with the high HI
titer of their sow (Figure 4B). Independently of their
lineage specificity, the HI titers decreased at week 3 (coin-
ciding with weaning) in all but one anti-HE positive
piglets, however, the percentages of positive animals
against both HE proteins remained constant until week 7
(Figure 4G). Up to that week, the reactivity to HE52.11
was circumscribed to piglets within litter A (Figure 4B).
At week 11, just 25% of the piglets (3/12) were reactive
against HE52.7, and a bare 20% presented anti-HE52.11
antibodies (Figure 4G). By week 15, 67% of the piglets
(8/12) were positive against HE52.11 (Figure 4G). Al-
though anti-HE52.7 reactivity was also observed in 33%(4/12) of the piglets, all those animals had higher HI titers
against HE52.11.
To compare the reactivity of each serum sample
against both HE52.7 and HE52.11 proteins the HI titers
obtained against the two HE proteins were plotted in
Figure 4H. While few samples had the same HI titers
with both proteins (serum samples found over the diag-
onal), most of them showed preferential reactivity with
one versus the other HE lineage (serum samples found
at both sides of the diagonal) and even some serum sam-
ples showed specific reactivity against only one of the
HE proteins (7 serum samples were positive only for the
HE52.7 and 5 were specific for the HE52.11). These data
clearly indicate that HE lineage specific amino acid dif-
ferences within the receptor domain were enough to
determine that antibodies developed against one lineage
do not interfere with the receptor recognition by the
other HE lineage.
Analysis of the antibody response to HE in pigs by ELISA
To further investigate the reactivity of antibodies in pig-
lets’ serum samples against HE52.7 and HE52.11 pro-
teins and the dynamics of antibodies against each of
them, an ELISA method using purified myc-tagged HE
proteins (HE52.7-myc and HE52.11-myc) as antigens
was used. The analysis by SDS-PAGE confirmed the
purity of both preparations and their reactivities with
both αHE polyclonal serum and anti-c-myc monoclonal
Figure 4 Analysis by HI assay of the reactivity of sera obtained from pigs at different ages against PToV-HE52.7 and PToV-HE52.11.
Extracts from BSC40 cells infected (MOI 5) for 24 h with rVV-HE52.7 (panels A, C and E) or rVV-HE52.11 (panels B, D and F) and treated with
DFP were diluted to contain 4 HAU in 25 μL PBS and incubated (1 h at 37 °C) with two-fold serial dilutions of pig sera prior to adding the mouse
RBC. Serum samples were obtained from animals belonging to three litters (litter A, panels A and B; litter B, panels C and D; litter C; panels
E and F) at different ages (1, 3, 7, 11 and 15 weeks) and from their sow (one-week post-farrowing). (G) Percentage of HI positive animals against
PToV-HE52.7 (blacK bars) and PToV-HE52.11 (grey bars) over the period studied. (H) Comparative analysis of HI titers of each serum sample against
PToV-HE52.7 and PToV-HE52.11 proteins. The results shown in the graphs are representative of two independent experiments.
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file 1).
All pig serum samples tested were positive against both
HE proteins by ELISA (Figure 5). One-week-old piglets
had O.D. values akin to those of their corresponding sow
against each HE protein. Piglets from litter A were highly
reactive against both HE52.7 and HE52.11, although the
ELISA values were slightly higher against the second one
(Figure 5A and 5B). Piglets from litter B, had a low re-
activity against both proteins (Figure 5C and 5D). In con-
trast, piglets from litter C showed a higher reactivity
against HE52.7 than against HE52.11 (Figure 5E and 5F).As it happened with HI titers, anti-HE reactivity by ELISA
gradually diminished with piglet’s age and by 7 weeks of
age, 4 weeks after weaning, it reached the lowest level in
most of the animals. At the next age analyzed (11 weeks),
most animals showed an increase in their anti-HE reacti-
vities against both PToV-HE proteins, and these kept
rising until 15 weeks of age at least.
To obtain an overview of the immune response against
both PToV-HE proteins, the mean ELISA reactivities
and HI titers of the serum samples from each litter
grouped by ages were compared side-by-side. As shown
in Figure 6, both assays revealed statistically significant
Figure 5 Reactivity of sera obtained from pigs at different ages against PToV-HE52.7 and PToV-HE52.11 determined by ELISA. Purified
HE52.7-myc- and HE52.11-myc proteins were used as coating antigen (62.5 ng/well). The same serum samples analyzed in Figure 4 were used in
the ELISA at a 1:100 dilution. IgG ELISA reactivities against HE52.7-myc- (panels A, C and E) and HE52.11-myc (panels B, D and F) of serum
samples from pigs and their sows are represented.
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mals from litters A and B, higher reactivity against HE52.11
was observed in the first weeks of the piglets’ life, although
low titers were observed in animals from litter B, which
were barely detectable by the HI assay. On the contrary, inFigure 6 Paired comparisons of the results of pig sera reactivities aga
Graphic representation of the mean HI (A) and ELISA (B) titers of sera grouped
(grey bars). Means ± standard error for each sample are shown. Asterisks ind
proteins (**p< 0.05, *p< 0.1; Student’s t test). The dotted lines indicate the rthe first weeks, animals from litter C had higher antibody
titers against HE52.7 by both assays. Also, from these re-
sults it is clear that sera from 15-week old animals from the
three litters reacted preferentially against HE52.11, indica-
ting a switch in antibody reactivity in animals from litter C.inst PToV-HE52.7 and PToV-HE52.11 determined by HI and ELISA.
by pig ages against both PToV-HE52.7 (black bars) and PToV-HE52.11
icate statistically significant differences of sera reactivity against the two
espective cut off values determined for each assay.
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The reactivity of the piglet’s sera against the highly con-
served N protein using a previously standardized ELISA
[23] has already been analyzed [20]. For comparison
with the anti-HE immune response here we provide the
results of the analysis of sera from the individual piglets
over time (see Additional file 2). Although there are dif-
ferences in the magnitude of the ELISA titers among the
different piglets, what is clear from these results is that
once maternally acquired antibodies had vanished, which
for the N protein occurs around weaning time (week 3
of age), all animals developed their own anti-N anti-
bodies that can readily be detected in most animals by
week 7. These findings were in agreement with those
obtained by HI and ELISA using the HE proteins as
antigen, and indicate that all animals become infected by
PToV soon after weaning.
Discussion
Despite the great advances recently made on HE know-
ledge, which include the elucidation of both BToV-HE
and PToV-HE tridimensional structures [12], the exact
role of the HE protein in the viral life cycle and the po-
tential relevance of the differences between HE lineages
in the immunological response to the virus remain un-
clear. Without an in vitro culture system and given the
great difficulties and costs of in vivo research, the use of
heterologous expression systems represents a useful and
relatively inexpensive approach to study the PToV-HE
protein. Here we used the recombinant VACV method-
ology to express two full PToV-HE sequences, HE52.7
and HE52.11, and their two corresponding soluble
fractions attached to a c-myc tag. Those HE coding
sequences had been previously identified during a tho-
rough longitudinal study of PToV in a Spanish farm
[20], and each of them were found to belong to one of
the two defined PToV-HE lineages [19]. These HE se-
quences were obtained from the same animal in sequen-
tial collection points. This finding indicated that both
lineages co-existed on the farm [20] although with ap-
parently different prevalences according to the age of
the host. This result could lead to new possibilities to
approach the PToV-HE behavior in the virus’ natural
environment.
Both recombinant proteins show similar features re-
garding their molecular weight, glycosylation degree,
and subcellular localization as those reported previously
for PToV and BToV [10,17], indicating that the re-
combinant HE proteins follow a correct biosynthetic
pathway. In addition, the heterologous expressed HE
proteins were fully functional as receptor binding-
receptor destroying enzymes since both PToV-HE pro-
teins were able to hemagglutinate mouse erythrocytes,
but also to hydrolyze the acetyl-ester linkage of glycanchains, as well as from acetylated synthetic compounds
like pNPA and ANAE.
The analysis of the amino acid changes found between
both PToV-HE lineages shows that there are amino acid
residues that are conserved in a lineage specific manner
even among strains identified in very distant geographic
areas (different European countries and Korea). This ana-
lysis also indicates that potential antigenic differences
would be mainly determined by residues located at the re-
ceptor binding domain, and exposed on the surface of the
protein according to the proposed structural model [12].
Hence, to elucidate if HE lineage specific changes could
determine antigenic differences on the receptor binding
domain, the HE 52.7 and 52.11 proteins were used as
model proteins in HI assays with field serum samples
from the same farm where both lineages were detected.
Significantly, by this assay most serum samples show pref-
erential reactivity to one of the HE proteins, or even spe-
cific reactivity against only one of them (see Figure 4H),
indicating the existence of antigenic differences between
the two HE lineages. Antigenic differences between HE
proteins from the two known BToV lineages have also
been described [17].
In addition, to study the antibody response against the
whole protein by a different approach, soluble c-myc
tagged HE52.7 and HE52.11 proteins were generated by
rVV methodology to obtain highly purified coating anti-
gens that were used in ELISA to test the same field serum
samples. Using both approaches, a high prevalence of anti-
bodies against PToV-HE was observed in both sows and
piglets. These results were in agreement with those ob-
tained using an ELISA assay with the very immunogenic
and highly conserved N protein as antigen [23].
In the present study, similar anti-HE response profiles
over time were observed by both HE-ELISA and the more
restricted lectin-specific HI test. A general decrease of
antibody levels was seen from the first weeks of age until
piglets’ reached week 7, related to the extinction of mater-
nally derived initial immunoglobulins. At 11-weeks of age,
immune levels recovered due to the development of the
pigs’ own response to infections, and they increased at
least until week 15. At this last sampled point, a general
increase of reactivity against HE52.11 (P4-like) was found
in animal sera from the three litters, indicative of the
prevalence of this lineage upon time. Overall, similar anti-
body patterns were observed by ELISA against the HE
proteins and the N protein, although a delay in both the
extinction of maternally derived antibodies and the de-
velopment of self-acquired antibodies against the HE
was observed in all animals analyzed (see Figure 5 and
Additional file 2).
The rising of antibodies to PToV antigens after weaning
can be explained as a consequence of the animal grouping
in livestock facilities for fattening purposes that provides
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the mixture of PToV strains in the same animal popu-
lation. Our results indicate that the immune response de-
veloped against one of the PToV lineages could not
protect against the infection by other PToV isolates car-
rying an HE protein belonging to a different lineage.
Hence, the specificity of the piglet’s current immune re-
sponse, its own or maternal, towards one or the other HE
lineage at a given time could determine the PToV strain
that could infect or prevail in the animal. Our hypothesis
is that this PToV lineage alternation could explain the sus-
tainment of both strains on the farm. In fact, even though
the P4-like (HE52.11) strain was not found by molecular
detection in piglets at the earliest ages [20], the high re-
activity observed by ELISA in sows and young piglets and,
more remarkably, by the HI in sow A and in 1-, 3- and
7-week old piglets from litter A meant that such a strain
was already circulating in the herd from the very begin-
ning of the sampling. Particularly, in piglet 52 the increa-
sing reactivity against both HE proteins from week 3 to
week 15 indicates a temporal coexistence of both types of
virus in the piglet at around weaning time. The lack of
anti-HE maternal antibodies with an HI capacity against
either HE protein might have facilitated the establishment
of both PToV strains early on in the piglet’s life. Although
we described that the two PToV-HE lineages were de-
tected within the same animal at two sequential sampling
time points, the lack of detection of PToV-HE52.11 at
week 7 could have been due to the low abundance of this
virus at the beginning of life, while at later times it became
predominant, and therefore easier to detect. Although the
shift from PToV-HE52.7 to PToV-HE52.11 in the ana-
lyzed animals (Markelo-like to P4-like strains) seems to
derive from immune pressure on the latter, the contri-
bution of a potential better viral fitness provided by the
former on older pigs’ tissue environments cannot be
discarded.
The tendency to recombine modules of their genomes
observed in Nidovirales, together with the extensive muta-
tion rates found, like in other RNA viruses, would faci-
litate the evasion of immune responses and the rapid
adaptation to new hosts and the new hosts’ environments.
From this study, where two PToV HE genotypes were
found co-existing on the same farm, we can speculate that
the specificity of the immune response towards one or the
other HE lineage in piglets at a given time could deter-
mine the PToV strain that prevailed and spread. However,
the potential additional contribution of the immune re-
sponse to other viral antigens in virus selection also has to
be considered. Future studies with higher numbers of ani-
mals from different farms will be required to further sup-
port the proposed hypothesis.
Though the PToV-HE protein in vivo function/s are
still to be undoubtedly defined, its persistence in fieldstrains, the tendency to undergo recombination events
and the different antigenic characteristics of both HE
lineages indicate that HE protein from torovirus plays an
important role in virus–host interactions with implica-
tions in immune protection that could explain the broad
spread of this virus in the pig population, causing
chronic infections/re-infections of the animals.
Additional files
Additional file 1: Analysis of purified PToV-HE52.7-myc and
PToV-HE52.11-myc proteins. (A) Cell extract from BSC40 cells infected
(MOI 5) with rVV-HE52.7-myc or rVV-HE52.11-myc (lysate), and affinity
purified HE52.7-myc and HE52.11-myc proteins (protein) were fractionated
by 10% SDS-PAGE, and the gel was stained with Coomassie blue. (B) Affinity
purified HE52.7-myc and HE52.11-myc proteins were reacted in Western blot
with the αmyc and αHE antibodies. Molecular size markers are given in kDa.
Additional file 2: Reactivity of sera obtained from pigs at different
ages against the N protein. The same serum samples analyzed in
Figure 4 were used in ELISA at a 1:100 dilution using the PToV-N protein
as antigen as previously described [23].
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